Overlapping and distinct molecular determinants dictating the antiviral activities of TRIM56 against flaviviruses and coronavirus

Journal of Virology

Volumn 88, Issue 23, 2014, Pages 13821-13835

  Liu, Baoming ^a   Li, Nan L ^a   Wang, Jie ^a,d   Shi, Pei Yong ^b   Wang, Tianyi ^c   Miller, Mark A ^a   Li, Kui ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b WADSWORTH CENTER   (United States)

^c SRI INTERNATIONAL   (United States)

^d PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TRIPARTITE MOTIF PROTEIN 56; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VIRUS PROTEIN; MUTANT PROTEIN; TRIM56 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CORONAVIRUS; DENGUE VIRUS 2; ENCEPHALOMYOCARDITIS VIRUS; ENZYME ACTIVITY; MOLECULAR MODEL; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS INHIBITION; VIRUS REPLICATION; YELLOW FEVER FLAVIVIRUS; CELL LINE; DENGUE VIRUS; DNA MUTATIONAL ANALYSIS; GENETICS; HUMAN; HUMAN CORONAVIRUS OC43; IMMUNOLOGY; PHYSIOLOGY; VIRUS ASSEMBLY; YELLOW FEVER VIRUS;

CORONAVIRUS;

CELL LINE; CORONAVIRUS OC43, HUMAN; DENGUE VIRUS; DNA MUTATIONAL ANALYSIS; ENCEPHALOMYOCARDITIS VIRUS; HUMANS; MUTANT PROTEINS; UBIQUITIN-PROTEIN LIGASES; VIRUS ASSEMBLY; VIRUS REPLICATION; YELLOW FEVER VIRUS;

EID: 84911361751     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02505-14     Document Type: Article

References (37)

1. Kawai T, Akira S. 2006. Innate immune recognition of viral infection. Nat. Immunol. 7:131-137. http://dx.doi.org/10.1038/ni1303.
2. Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11:373-384http://dx.doi.org/10.1038/ni.1863.
3. Yoneyama M, Fujita T. 2010. Recognition of viral nucleic acids in innate immunity. Rev. Med. Virol. 20:4-22. http://dx.doi.org/10.1002/rmv.633.
4. Lester SN, Li K. 2014. Toll-Like receptors in antiviral innate immunity. J. Mol. Biol. 426:1246-1264. http://dx.doi.org/10.1016/j.jmb.2013.11.024.
5. Baumann JG. 2006. Intracellular restriction factors in mammalian cells-an ancient defense system finds a modern foe. Curr. HIV. Res. 4:141-168. http://dx.doi.org/10.2174/157016206776055093.
6. Munir M. 2010. TRIM proteins: another class of viral victims. Sci. Signal. 3:jc2. http://dx.doi.org/10.1126/scisignal.3118jc2.
7. Rajsbaum R, García-Sastre A, Versteeg GA. 2014. TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity. J. Mol. Biol. 426:1265-1284. http://dx.doi.org/10.1016/j.jmb.2013.12.005.
8. Kawai T, Akira S. 2011. Regulation of innate immune signalling pathways by the tripartite motif (TRIM) family proteins. EMBO Mol. Med. 3:513-527http://dx.doi.org/10.1002/emmm.201100160.
9. Ozato K, Shin DM, Chang TH, Morse HC, III. 2008. TRIM family proteins and their emerging roles in innate immunity. Nat. Rev. Immunol. 8:849-860. http://dx.doi.org/10.1038/nri2413.
10. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. 2004. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427:848-853. Http://dx.doi.org /10.1038/nature02343.
11. Taylor RT, Lubick KJ, Robertson SJ, Broughton JP, Bloom ME, Bresnahan WA, Best SM. 2011. TRIM79α, an interferon-stimulated gene product, restricts tick-borne encephalitis virus replication by degrading the viral RNA polymerase. Cell Host Microbe 10:185-196. Http://dx.doi .org/10.1016/j.chom.2011.08.004.
12. Wang J, Liu B, Wang N, Lee YM, Liu C, Li K. 2011. TRIM56 is a virusand interferon-inducible E3 ubiquitin ligase that restricts pestivirus infection. J. Virol. 85:3733-3745. http://dx.doi.org/10.1128/JVI.02546-10.
13. Heinz FX, Stiasny K. 2012. Flaviviruses and flavivirus vaccines. Vaccine 30:4301-4306. http://dx.doi.org/10.1016/j.vaccine.2011.09.114.
14. Shen Y, Li NL, Wang J, Liu B, Lester S, Li K. 2012. TRIM56 is an essential component of the TLR3 antiviral signaling pathway. J. Biol. Chem. 287:36404-36413. http://dx.doi.org/10.1074/jbc.M112.397075.
15. Chen Z, Benureau Y, Rijnbrand R, Yi J, Wang T, Warter L, Lanford RE, Weinman SA, Lemon SM, Martin A, Li K. 2007. GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS. J. Virol. 81:964-976. http://dx.doi.org/10.1128/JVI.02076-06.
16. Xie X, Wang QY, Xu HY, Qing M, Kramer L, Yuan Z, Shi PY. 2011. Inhibition of dengue virus by targeting viral NS4B protein. J. Virol. 85: 11183-11195. http://dx.doi.org/10.1128/JVI.05468-11.
17. Liu S, Qiu C, Miao R, Zhou J, Lee A, Liu B, Lester SN, Fu W, Zhu L, Zhang L, Xu J, Fan D, Li K, Fu M, Wang T. 2013. MCPIP1 restricts HIV infection and is rapidly degraded in activated CD4 T cells. Proc. Natl. Acad. Sci. U. S. A. 110:19083-19088. Http://dx.doi.org/10.1073/pnas .1316208110.
18. Zhou Z, Wang N, Woodson SE, Dong Q, Wang J, Liang Y, Rijnbrand R, Wei L, Nichols JE, Guo JT, Holbrook MR, Lemon SM, Li K. 2011. Antiviral activities of ISG20 in positive-strand RNA virus infections. Virology 409:175-188. http://dx.doi.org/10.1016/j.virol.2010.10.008.
19. Wang N, Liang Y, Devaraj S, Wang J, Lemon SM, Li K. 2009. Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells. J. Virol. 83:9824-9834. Http://dx.doi.org/10.1128 /JVI.01125-09.
20. Li K, Chen Z, Kato N, Gale M, Jr, Lemon SM. 2005. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J. Biol. Chem. 280:16739-16747. Http://dx.doi.org/10 .1074/jbc.M414139200.
21. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, Ray SC, Gale M, Jr, Lemon SM. 2005. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. U. S. A. 102:2992-2997. Http://dx.doi .org/10.1073/pnas.0408824102.
22. Wang N, Dong Q, Li J, Jangra RK, Fan M, Brasier AR, Lemon SM, Pfeffer LM, Li K. 2010. Viral induction of the zinc-finger antiviral protein is IRF3-dependent but NF-kappa B-independent. J. Biol. Chem. 285: 6080-6090. http://dx.doi.org/10.1074/jbc.M109.054486.
23. van Elden LJ, van Loon AM, van Alphen F, Hendriksen KA, Hoepelman AI, van Kraaij MG, Oosterheert JJ, Schipper P, Schuurman R, Nijhuis M. 2004. Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel realtime reverse-transcriptase polymerase chain reaction. J. Infect. Dis. 189: 652-657. http://dx.doi.org/10.1086/381207.
24. Wang RY, Li K. 2012. Host factors in the replication of positive-strand RNA viruses. Chang Gung Med. J. 35:111-124.
25. Tsuchida T, Zou J, Saitoh T, Kumar H, Abe T, Matsuura Y, Kawai T, Akira S. 2010. The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA. Immunity 33:765-776. http://dx.doi.org/10.1016/j.immuni.2010.10.013.
26. Keskinen P, Nyqvist M, Sareneva T, Pirhonen J, Melén K, Julkunen I. Impaired antiviral response in human hepatoma cells. Virology 263: 364-375. http://dx.doi.org/10.1006/viro.1999.9983.
27. Jiang D, Guo H, Xu C, Chang J, Gu B, Wang L, Block TM, Guo JT. Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J. Virol. 82:1665-1678. Http: //dx.doi.org/10.1128/JVI.02113-07.
28. de Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L, Fouchier RA, Galiano M, Gorbalenya AE, Memish ZA, Perlman S, Poon LL, Snijder EJ, Stephens GM, Woo PC, Zaki AM, Zambon M, Ziebuhr J. 2013. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J. Virol. 87:7790-7792. http://dx.doi.org/10.1128/JVI.01244-13.
29. Barber GN. 2011. Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses. Curr. Opin. Immunol. 23:10-20. Http://dx.doi.org/10.1016/j.coi.2010.12 .015.
30. Cai X, Chiu YH, Chen ZJ. 2014. The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling. Mol. Cell 54:289-296. Http://dx.doi .org/10.1016/j.molcel.2014.03.040.
31. Di Pietro A, Kajaste-Rudnitski A, Oteiza A, Nicora L, Towers GJ, Mechti N, Vicenzi E. 2013. TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation. J. Virol. 87:4523-4533 http://dx.doi.org/10.1128/JVI.02548-12.
32. Uchil PD, Quinlan BD, Chan WT, Luna JM, Mothes W. 2008. TRIM E3 ligases interfere with early and late stages of the retroviral life cycle. PLoS Pathog. 4:e16. http://dx.doi.org/10.1371/journal.ppat.0040016.
33. Napolitano LM, Jaffray EG, Hay RT, Meroni G. 2011. Functional interactions between ubiquitin E2 enzymes and TRIM proteins. Biochem. J. 434:309-319. http://dx.doi.org/10.1042/BJ20101487.
34. Sanchez JG, Okreglicka K, Chandrasekaran V, Welker JM, Sundquist WI, Pornillos O. 2014. The tripartite motif coiled-coil is an elongatedantiparallel hairpin dimer. Proc. Natl. Acad. Sci. U. S. A. 111:2494-2499. http://dx.doi.org/10.1073/pnas.1318962111.
35. Gack MU, Shin YC, Joo CH, Urano T, Liang C, Sun L, Takeuchi O, Akira S, Chen Z, Inoue S, Jung JU. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916-920. http://dx.doi.org/10.1038/nature05732.
36. Liang Q, Deng H, Li X, Wu X, Tang Q, Chang TH, Peng H, Rauscher FJ, III, Ozato K, Zhu F. 2011. Tripartite motif-containing protein 28 is a small ubiquitin-related modifier E3 ligase and negative regulator of IFN regulatory factor 7. J. Immunol. 187:4754-4763. Http://dx.doi.org/10 .4049/jimmunol.1101704.
37. Zou W, Zhang DE. 2006. The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase. J. Biol. Chem. 281:3989-3994. http://dx.doi.org/10.1074/jbc.M510787200.